Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study

被引：9
|
作者：
Pratz, Keith W.
DiNardo, Courtney D.
Selleslag, Dominik
Li, Junmin
Yamamoto, Kazuhito
Konopleva, Marina
McDonald, Andrew
Babu, Sunil
Stevens, Don A.
Kantarjian, Hagop M.
Traina, Fabiola
Venditti, Adriano
Mayer, Jiri
Montez, Melissa
Ramsingh, Giridharan
Jin, Huan
Ainsworth, William
Duan, Yinghui
Svensson, Anders Erik
Werner, Michael
Potluri, Jalaja
Jonas, Brian A.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134832
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study
    Garcia-Manero, Guillermo
    Abaza, Yasmin
    Takahashi, Koichi
    Medeiros, Bruno C.
    Arellano, Martha
    Khaled, Samer K.
    Patnaik, Mrinal
    Odenike, Olatoyosi
    Sayar, Hamid
    Tummala, Mohan
    Patel, Prapti
    Maness-Harris, Lori
    Stuart, Robert
    Traer, Elie
    Karamlou, Kasra
    Yacoub, Abdulraheem
    Ghalie, Richard
    Giorgino, Ruben
    Atallah, Ehab
    BLOOD ADVANCES, 2019, 3 (04) : 508 - 518
  • [22] Updated efficacy and safety data from the AGILE study in patients with newly diagnosed acute myeloid leukemia treated with ivosidenib plus azacitidine compared to placebo plus azacitidine.
    De Botton, Stephane
    Montesinos, Pau
    Polo, Susana Vives
    Zarzycka, Ewa
    Wang, Jianxiang
    Riva, Marta
    Heuser, Michael
    Calado, Rodrigo T.
    Schuh, Andre C.
    Yeh, Su-Peng
    Hui, Jianan
    Gianolio, Diego A.
    Patel, Prapti Arvind
    Recher, Christian
    Dohner, Hartmut
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Updated efficacy and safety data from the AGILE study in patients with newly-diagnosed acute myeloid leukemia treated with ivosidenib plus azacitidine compared to placebo plus azacitidine
    Heuser, M.
    Montesinos, P.
    Vives, Polo S.
    Zarzycka, E.
    Wang, J.
    Riva, M.
    Calado, R. T.
    Schuh, A. C.
    Yeh, S. -P
    Hui, J.
    Gianolio, D. A.
    Patel, P.
    Recher, C.
    de Botton, S.
    Doehner, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 95 - 95
  • [24] Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment
    Ikezoe, Takayuki
    Usuki, Kensuke
    Aida, Kensuke
    Hatayama, Tomoyoshi
    Shirahase, Toru
    Yamauchi, Takahiro
    CANCER SCIENCE, 2023, 114 (03) : 1037 - 1044
  • [25] Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients with Acute Myeloid Leukemia and Adverse Risk Features
    Gutman, Jonathan A.
    Winters, Amanda
    Amaya, Maria L.
    McMahon, Christine M.
    Schowinsky, Jeffrey
    Abbott, Diana
    Hammes, Andrew
    Pei, Shanshan
    Stevens, Brett M.
    Jordan, Craig T.
    Smith, Clayton
    Pollyea, Daniel A.
    BLOOD, 2020, 136
  • [26] Oral azacitidine plus venetoclax in patients with relapsed/refractory or newly diagnosed acute myeloid leukemia: The phase 1b OMNIVERSE trial.
    Ravandi, Farhad
    Carraway, Hetty E.
    Taningco, Lilia
    Laille, Eric
    Gong, Jing
    Prebet, Thomas
    De Menezes, Daniel Lopes
    Wei, Andrew H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia
    Ramdohr, Florian
    Hennings, Robert
    Monecke, Astrid
    Kayser, Sabine
    HAEMATOLOGICA, 2023, 108 (07) : 1965 - 1967
  • [28] First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab plus Azacitidine plus Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)
    Jaddaoui, Samiha
    Bencharef, Hanaa
    Addakiri, Sara
    Dehbi, Hind
    Lamchahab, Mouna
    Quessar, Asmaa
    Madani, Abdellah
    Oukkache, Bouchra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S255 - S256
  • [29] First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab plus Azacitidine plus Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)
    Zeidan, Amer M.
    Westermann, Joerg
    Kovacsovics, Tibor
    Assouline, Sarit
    Schuh, Andre C.
    Kim, Hee-Je
    Macias, Gabriela Rodriguez
    Sanford, David
    Luskin, Marlise R.
    Stein, Eytan M.
    Malek, Kamel
    Lyu, Jiaying
    Stegert, Mario
    Esteve, Jordi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S255 - S255
  • [30] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
    Guinan, Kimberly
    Mathurin, Karine
    Au, Yunghan
    Schuh, Andre C.
    Bui, Cat N.
    Chai, Xinglei
    Lachaine, Jean
    CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536
12345